Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys (FG7142/RO15-1788 
The unique sensitivity of the prefrontal cortical dopamine system to mild stress has been the focus of intensive investigation (1) due to its potential relevance to psychiatric disorders, including the exacerbation or precipitation of psychotic episodes (2) (3) (4) . Prefrontal cortical dysfunction has been implicated in schizophrenia (5, 6) , and alterations in the function of the prefrontal dopamine innervation are thought to underly some of the cognitive and affective symptoms associated with this disease (7, 8) .
Despite considerable research into the biochemical and pharmacological regulation of dopamine release and turnover in the prefrontal cortex (1, 9), the impact of increased dopamine turnover on prefrontal cortical function has not been directly explored. In the present study, we have examined this question by exploiting the finding that the anxiogenic ,B-carboline, FG7142, reproduces the biochemical effects of mild stress on prefrontal cortex by eliciting a selective and significant increase in dopamine turnover and release (1, [10] [11] [12] [13] [14] .
The behavioral effects of FG7142 administration were examined in both rats and monkeys performing working memory tasks which depend on prefrontal cortical functioning (15) (16) (17) (18) (19) (20) (21) (22) . Previous research has shown that the spatial working memory functions of the prefrontal cortex are dependent upon the integrity of the dopamine neurons: experimental depletion of dopamine restricted to the prefrontal cortex can lead to working memory deficits in monkeys and rats (23) (24) (25) (26) . The results of the current study suggest that excessive dopaminereceptor stimulation in the prefrontal cortex is also detrimen-
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tal to prefrontal cortical cognitive functioning in both rodents and monkeys.
MATERIALS AND METHODS Subjects. Subjects were male Sprague-Dawley (CAMM) rats (Charles River Breeding Laboratories) and four female rhesus monkeys. All rats had access to water ad lib. Rats used only in the biochemical study had ad lib access to rat chow, while rats and monkeys in the behavioral studies were limited to small quantities of standard chow immediately following cognitive testing.
Behavioral Testing. Delayed alternation testing was performed in a standard T maze. On the first trial, rats were rewarded for traversing the runway and entering either arm. Thereafter, for a total of 10 trials per session, rats were rewarded only if they entered the maze arm which was not previously chosen. The intertrial delay, during which the rat was confined to the start box of the runway, was adjusted until a rat's performance stabilized at 80% correct, to allow for detection of either improvement or impairment during drug administration.
During spatial discrimination testing in the same T maze, rats were rewarded for always choosing either the left or the right arm. Half of the animals were rewarded for entering the right arm, and half were rewarded for entering the left. The intertrial delay was adjusted so that a rat was performing at or below 90% correct, to allow for detection of either improvement or impairment following drug administration.
Monkeys were tested on delayed response according to the methods of Brozoski et al. (23) benzodiazepine antagonist which blocks the stress-induced incre'ase in prefrontal cortical dopamine turnover (12) , prevented the delayed alternation deficit induced by FG7142 in the rat (Fig. 2) . When given alone, RO15-1788 produced a small but significant impairment of performance in the rat. Pretreatment with R0151788 in the monkey had no effect alone but also Cattenuated the FG7142-induced cognitive impairment (Fig. 3) .
To examine whether animals given FG7142 were impaired as a result of nonspecific changes in behavior, rats (it = 21) (n = 18)(n = 5)(n = 5) (n = 6)(t -11) (ti = 5)(n -8) (n = 5) (n = 6)
Effects of FG7142, R015-1788, and dopamine antagonists on delayed alternation performance in the rat. FG7142 (FG; 20 mg/kg) produced a significant impairment in the accuracy of response on the delayed alternation task when compared to an animal's performance on vehicle (VEH; FG vs. VEH, P = 0.001). There was a small but significant impairment of delayed alternation with R015-1788 (RO; 20 mg/kg) when given alone (RO vs VEH, P = 0.03). However, pretreatment with R015-1788 prevented the FG7142-induced impairment of delayed alternation (RO/FG vs. FG, P < 0.001). Haloperidol (HAL; 0.1-0.15 mg/kg) and clozapine (CLZ; 2.5 mg/kg) had no effect on delayed alternation performance when given alone. In contrast, SCH23390 (SCH; 0.035 mg/kg) produced a slight but significant impairment of cognitive performance when given alone (SCH vs. VEH, P = 0.05). Haloperidol, clozapine, and SCH23390 ameliorated the FG7142-associated cognitive impairment when given as a pretreatment (HAL/FG vs. FG, P = 0.004; CLZ/FG vs. FG, P = 0.001; SCH/FG vs. FG, P = 0.002). *, P < 0.001 vs. VEH; **, P < 0.001 vs. FG; ***, P < 0.05 vs. VEH. on a spatial discrimination task, which has the same motor and motivational requirements as delayed alternation but is not dependent on the prefrontal cortex. In contrast to delayed alternation performance, spatial discrimination was unaffected by FG7142 (Fig. 4) . The 0-sec delay condition in delayed response provides a control for examining possible nonspecific effects of FG7142 in monkeys, as this condition does not require spatial working memory. An examination of the 0-sec delay condition found no effect of FG7142 on performance accuracy in monkeys.
In addition, the locomotor effects of FG7142 were examined to determine whether the FG7142-induced impairment might be related to impaired motor abilities. A repeated-measures ANOVA indicated that FG7142 had no effect on the levels of total activity for 30 min following injection. Dopamine Turnover in the Prefrontal Cortex Correlates with Spatial Working Memory Performance Deficits in the Rat. At the end of the behavioral study, rats were given FG7142 or vehicle, tested on the delayed alternation task, and sacrificed immediately after testing. As with previous biochemical findings, postmortem quantitation of dopamine and DOPAC indicated that FG7142 significantly increased dopamine turnover in the prefrontal cortex. Furthermore, there was a significant correlation between increased dopamine turnover in the prefrontal cortex and impaired accuracy of delayed alternation performance (Fig. 5) . Thus, the animals exhibiting the worst performance on the delayed alternation task had the highest levels of dopamine turnover in the prefrontal cortex.
Dopamine Antagonist Pretreatment Prevents FG7142-Induced Cognitive Impairments in the Rat and Monkey. The involvement of excess dopamine in the FG7142-induced prefrontal cortical-dependent cognitive deficits was examined by determining whether dopamine antagonists with three different receptor subtype profiles could block the impairment induced by FG7142 (Figs. 2 and 3 ).
Delayed alternation performance in rats was protected from FG7142-induced cognitive impairment by pretreatment with low doses of the nonspecific dopamine receptor antagonist and typical antipsychotic drug haloperidol (0.1-0.2 mg/kg). Haloperidol did not impair delayed alternation performance in rats when given alone. However, haloperidol pretreatment blocked the delayed response impairment associated with FG7142. As in rats, haloperidol (0.005 mg/kg) blocked the FG7142-impaired performance in monkeys. As haloperidol impairs delayed alternation performance in monkeys when given alone, additive drug effects cannot account for this improvement.
Delayed alternation performance in the rat was also protected from FG7142-induced cognitive impairment by pretreatment with low doses of the atypical antipsychotic drug clozapine (2.5 mg/kg), a nonspecific dopamine receptor antagonist with 5-HT2 receptor affinity. The FG7142-associated cognitive deficits in the monkey were also prevented by pretreatment with clozapine (1-6 mg/kg). Clozapine did not impair cognitive performance when given alone in either the rat or the monkey.
The Di receptor-selective antagonist SCH23390 (0.035 mg/ kg) was also able to attenuate the FG7142-induced cognitive impairment in the rat. In the monkey, SCH23390 (0.01 mg of SCH23390 maleate per kg) ameliorated the cognitive impairment associated with FG7142 administration. In monkeys and rats, SCH23390 treatment produced a significant impairment of performance accuracy when given alone.
DISCUSSION
The pharmacological stressor FG7142 selectively activates the mesoprefrontal cortical dopamine system and impairs response accuracy on working memory tasks. As expected from previous studies (12, 14, 28 -ZT mg/kg, i.m.) produced an impairment on delayed response, a spatial working memory task, with no effect at the 0-sec delay condition. Doses of the benzodiazepine antagonist R015-1788 which prevent FG7142-induced increases in dopamine metabolism in the prefrontal cortex (12) also prevented the cognitive impairment produced by administration of FG7142. In addition, the strong correlation between increased dopamine turnover in the prefrontal cortex and impaired delayed alternation performance suggests that increased dopamine receptor stimula- tion in the prefrontal cortex underlies the cognitive deficits produced by FG7142 treatment. This hypothesis is supported by the finding that FG7142-induced cognitive deficits were blocked by pretreatment with dopamine receptor antagonists. Furthermore, the fact that SCH23390 prevents the FG7142-induced cognitive impairment suggests that postsynaptic Dlreceptor blockade underlies at least a portion of the amelioration by both haloperidol and clozapine. The ability of haloperidol, clozapine, and SCH23390 to ameliorate the FG7142-induced cognitive deficit also suggests a dopaminergic mechanism, but it should be noted that these dopamine antagonists have some ability to bind to nondopamine receptors. In addition, FG7142 can alter the activity of other neurotransmitter systems (32, 33) . While the involvement of nondopamine systems cannot be ruled out, drugs which target the serotonergic (fluoxetine) and noradrenergic (propranolol) neurotransmitter systems do not appear to alter FG7142-impaired cognitive responses using a delayed alternation paradigm in rats (unpublished results). The interpretation that the cognitive deficits observed in these experiments are due to large increases in dopamine-receptor activation finds support from recent single unit experiments in monkeys. lontophoretic application of moderate doses of the dopamine agonist SKF38393 inhibited the delay-period neuronal activity related to the mnemonic component of a delayed response task (34) .
Prefrontal cortical dysfunction is thought to contribute to the symptoms of a number of psychiatric disorders. Patients with schizophrenia, Tourette syndrome, Parkinson disease, and attention deficit/hyperactivity disorder exhibit many symptoms of prefrontal cortex dysfunction (5, (35) (36) (37) . Abnormal dopamine regulation in the prefrontal cortex (7, 38) and hypofrontality (39) have been postulated to be involved in the etiology of schizophrenia. The sensitivity of the prefrontal cortex to stress may underlie part of the sequelae associated with the stress-induced precipitation or exacerbation of psychosis (2-4).
The cognitive changes of Parkinson disease, as well as the hallmark motor impairments, have been linked to dopaminedepleted circuits (37, 40, 41) . However, in L-dopa-treated Parkinsonian patients, apomorphine can induce cognitive deficits (42) . Consistent with the current study, these findings support the idea that excessive dopamine-receptor stimulation can be detrimental to cognitive function.
Our experimental findings correlating impaired prefrontal cortex cognitive abilities with increased prefrontal cortex dopamine turnover complement previous studies indicating that dopamine depletion impairs prefrontal cortex cognitive function (23) . The present study suggests that there may be a critical range of dopaminergic activity for optimal prefrontal cortex-dependent cognitive functioning and that exceeding this range can result in dysregulation and cognitive impairment. These findings highlight the role of dopamine in prefrontal cortex-dependent cognition and may provide new insights into better treatment strategies for psychiatric disorders associated with dysregulation of prefrontal cortical dopamine function.
